Delivery Order SPE2DB25D3108-SPE2DB25FPEAH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 8 MG tablets (30-count supply) valued at $1,752.54 under a firm fixed price contract type. The delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 mg tablets (30-count units) valued at $2,094.26 on September 23, 2025, with completion scheduled for September 24, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed through AmerisourceBergen's existing contract vehicle with DLA. FYCOMPA (perampanel) is an oral antiepileptic medication used as adjunctive therapy for partial-onset seizures and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of FYCOMPA 4 mg tablets (30-count units) with a ceiling value of $3,134.37. This firm fixed-price delivery order, which has an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,965.36 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 2 mg tablets (30-count units) on May 30, 2025, with a completion date of June 2, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,148.08 by the Defense Logistics Agency on August 5, 2025, for the supply of Fycompa 4 mg tablets (30-count). This firm fixed-price delivery order, which concludes on August 6, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $2,067.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 MG tablets (30-count packaging) on July 10, 2025, with completion expected by July 11, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,027.44 for Fycompa 8 mg tablets (30-count) with an ultimate completion date of September 5, 2025. This competitive delivery order, issued under firm fixed-price terms with no set-aside designation, represents a single pharmaceutical supply transaction fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Fycompa 2 mg tablets (30-count units) valued at $1,493.69. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 14, 2025, valued at $1,489.87 for the supply of Fycompa 2 mg tablets (30-count packages) under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order issued by the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $1,580.41 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fycompa 8 mg tablets (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance. This...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPEAHDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 23, 2025, for FYCOMPA 4 mg tablets (30-count package) with a ceiling value of $2,067.96. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 24, 2025, and the place of performance is located in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The DLA procures pharmaceutical products and medical supplies to support military healthcare systems and federal medical needs. FYCOMPA (perampanel) is an anticonvulsant medication used in neurological treatment applications. AmerisourceBergen's federal contract portfolio demonstrates its role as a critical pharmaceutical distributor for military and veteran healthcare systems, with the company consistently delivering a wide range of medications across multiple therapeutic domains through competitive awards. The parent IDC with DLA enables AmerisourceBergen to supply pharmaceutical products globally to support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/23/25 |